Dr. Michael Ruddy, M.D

NPI: 1831138015
Total Payments
$874.76
2024 Payments
$297.66
Companies
17
Transactions
37
Medicare Patients
2,097
Medicare Billing
$355,057

Payment Breakdown by Category

Food & Beverage$861.16 (98.4%)
Education$13.60 (1.6%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $861.16 36 98.4%
Education $13.60 1 1.6%

Top Paying Companies

Company Total Records Latest Year
Otsuka America Pharmaceutical, Inc. $263.54 4 $0 (2024)
Amgen Inc. $138.60 4 $0 (2024)
Aurinia Pharma U.S., Inc. $80.02 5 $0 (2024)
Relypsa, Inc. $54.92 4 $0 (2019)
Novartis Pharmaceuticals Corporation $53.62 3 $0 (2024)
Fresenius USA Marketing, Inc. $49.38 3 $0 (2023)
Bayer Healthcare Pharmaceuticals Inc. $36.78 2 $0 (2024)
Calliditas Therapeutics US Inc. $33.35 2 $0 (2023)
Ardelyx, Inc. $32.24 2 $0 (2024)
Vifor Pharma, Inc. $24.87 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $297.66 13 Amgen Inc. ($113.21)
2023 $194.32 11 Aurinia Pharma U.S., Inc. ($48.44)
2022 $30.76 2 Fresenius USA Marketing, Inc. ($17.06)
2020 $122.19 1 Otsuka America Pharmaceutical, Inc. ($122.19)
2019 $147.87 4 Otsuka America Pharmaceutical, Inc. ($106.36)
2018 $54.93 4 Relypsa, Inc. ($26.95)
2017 $27.03 2 Arbor Pharmaceuticals, Inc. ($13.76)

All Payment Transactions

37 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
11/11/2024 Otsuka Pharmaceutical Development & Commercialization, Inc. Food and Beverage In-kind items and services $16.83 General
10/22/2024 Aurinia Pharma U.S., Inc. LUPKYNIS (Drug) Food and Beverage In-kind items and services $15.29 General
Category: LUPUS NEPHRITIS
10/16/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $15.19 General
Category: Cardio-renal
10/08/2024 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $20.93 General
Category: NEPHROLOGY
09/04/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Food and Beverage In-kind items and services $14.22 General
Category: Immunology
08/13/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage In-kind items and services $96.69 General
Category: Inflammation
05/14/2024 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $17.50 General
03/20/2024 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $14.06 General
Category: NEPHROLOGY
03/19/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $15.68 General
Category: GASTROENTEROLOGY
03/11/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $16.56 General
Category: GASTROENTEROLOGY
03/05/2024 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $21.90 General
03/01/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $16.52 General
Category: Inflammation/Rare Disease
02/12/2024 Aurinia Pharma U.S., Inc. LUPKYNIS (Drug) Food and Beverage In-kind items and services $16.29 General
Category: LUPUS NEPHRITIS
12/28/2023 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage In-kind items and services $15.87 General
Category: Diabetes
12/11/2023 Travere Therapeutics, Inc. Food and Beverage In-kind items and services $13.97 General
12/11/2023 Calliditas Therapeutics US Inc. TARPEYO (Drug) Education Cash or cash equivalent $13.60 General
Category: Nephrology
10/25/2023 Aurinia Pharma U.S., Inc. LUPKYNIS (Drug) Food and Beverage In-kind items and services $14.82 General
Category: LUPUS NEPHRITIS
10/16/2023 Fresenius USA Marketing, Inc. Velphoro (Drug), KORSUVA Food and Beverage In-kind items and services $17.20 General
Category: Phosphate binder for ESRD
08/14/2023 FRESENIUS USA MANUFACTURING, INC. Velphoro (Drug), KORSUVA Food and Beverage In-kind items and services $19.03 General
Category: Phosphate binder for ESRD
08/02/2023 Calliditas Therapeutics US Inc. TARPEYO (Drug) Food and Beverage In-kind items and services $19.75 General
Category: Nephrology
06/26/2023 Aurinia Pharma U.S., Inc. LUPKYNIS (Drug) Food and Beverage In-kind items and services $16.07 General
Category: LUPUS NEPHRITIS
03/29/2023 Aurinia Pharma U.S., Inc. LUPKYNIS (Drug) Food and Beverage In-kind items and services $17.55 General
Category: LUPUS NEPHRITIS
02/28/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $21.59 General
Category: Cardio-renal
02/08/2023 Vifor Pharma, Inc. Veltassa (Drug) Food and Beverage In-kind items and services $24.87 General
Category: Hyperkalemia
10/24/2022 Fresenius USA Marketing, Inc. Velphoro (Drug) Food and Beverage In-kind items and services $17.06 General
Category: Phosphate binder for ESRD

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 471 891 $155,050 $82,954
2022 9 552 942 $168,525 $86,039
2021 10 615 1,060 $198,927 $107,570
2020 7 459 816 $175,635 $78,494
Total Patients
2,097
Total Services
3,709
Medicare Billing
$355,057
Procedure Codes
32

All Medicare Procedures & Services

32 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 105 256 $62,720 $36,097 57.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 164 296 $53,280 $29,428 55.2%
99091 Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days Office 2023 132 269 $24,210 $11,979 49.5%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 22 22 $7,040 $4,009 56.9%
93784 Ambulatory blood pressure monitoring, 1 day or longer, with recording, scanning analysis, interpretation, and report Office 2023 24 24 $6,600 $945.12 14.3%
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional Office 2023 24 24 $1,200 $495.36 41.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 116 252 $61,740 $36,292 58.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 156 263 $47,340 $24,799 52.4%
99091 Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days Office 2022 131 251 $22,590 $11,789 52.2%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 39 48 $12,480 $4,306 34.5%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 19 19 $5,980 $3,687 61.6%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 38 56 $10,360 $3,435 33.2%
93784 Ambulatory blood pressure monitoring, 1 day or longer, with recording, scanning analysis, interpretation, and report Office 2022 21 21 $5,775 $770.83 13.3%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2022 11 11 $1,210 $559.71 46.3%
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional Office 2022 21 21 $1,050 $400.64 38.2%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 113 296 $72,520 $44,879 61.9%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 173 335 $60,300 $35,119 58.2%
99091 Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days Office 2021 117 175 $15,182 $8,542 56.3%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 50 68 $17,680 $6,188 35.0%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 60 82 $15,170 $5,083 33.5%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 26 26 $8,060 $4,939 61.3%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2021 12 14 $1,540 $1,141 74.1%
93784 Ambulatory blood pressure monitoring, 24 hours or longer, with recording, scanning analysis, interpretation, and report Office 2021 25 25 $6,875 $1,028 15.0%
99211 Established patient outpatient visit, minimal presenting problem Office 2021 25 25 $1,250 $518.25 41.5%
99474 Self-measured blood pressure measurements Office 2021 14 14 $350.00 $133.00 38.0%

About Dr. Michael Ruddy, M.D

Dr. Michael Ruddy, M.D is a Specialist healthcare provider based in Princeton Junction, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831138015.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Ruddy, M.D has received a total of $874.76 in payments from pharmaceutical and medical device companies, with $297.66 received in 2024. These payments were reported across 37 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($861.16).

As a Medicare-enrolled provider, Ruddy has provided services to 2,097 Medicare beneficiaries, totaling 3,709 services with total Medicare billing of $355,057. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.

Practice Information

  • Specialty Specialist
  • Location Princeton Junction, NJ
  • Active Since 06/05/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 174400000X
  • Entity Type Individual
  • NPI Number 1831138015

Products in Payments

  • JYNARQUE (Drug) $263.54
  • TAVNEOS (Drug) $96.69
  • LUPKYNIS (Drug) $80.02
  • Veltassa (Drug) $79.79
  • Velphoro (Drug) $68.41
  • Kerendia (Drug) $36.78
  • TARPEYO (Drug) $33.35
  • IBSRELA (Drug) $32.24
  • Parsabiv (Biological) $25.39
  • KRYSTEXXA (Biological) $16.52
  • JARDIANCE (Drug) $15.87
  • ACTHAR (Biological) $14.28
  • Fabhalta (Drug) $14.22
  • Edarbi (Drug) $13.76
  • FARXIGA (Drug) $13.70

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Specialist Doctors in Princeton Junction